KMO and acute kidney injury: In an experimental AKI model induced by kidney ischemia-reperfusion injury (IRI), inhibiting KMO activity using GSK065, GSK366, and GSK428, as well as downregulating its expression, preserved renal function and reduced renal tubular cell injury.